Skip to content
Study details
Enrolling now

Induction of Dreaming With EEG and Anesthesia for Post-traumatic Stress Disorder

Stanford University
NCT IDNCT06577636ClinicalTrials.gov data as of Apr 2026
Phase

Phase 2

Target enrollment

42

Study length

about 1.4 years

Ages

18–70

Locations

1 site in CA

About this study

Researchers are testing whether anesthesia-induced dreaming can help reduce symptoms of PTSD. The trial will involve adults who have PTSD, and they will receive either deep sedation to induce dreams or light sedation without loss of responsiveness. Researchers are comparing these two approaches to see which one leads to a greater reduction in PTSD symptoms.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Undergo Propofol anesthesia
PhasePhase 2
DrugPropofol anesthesia
Routeinjection
Primary goalClinician-Administered PTSD Scale for DSM-5 (CAPS-5)

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low13%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Drug classes

general anesthetic (Facilitates GABA; induces unconsciousness)

Drug routes

injection (Injection)

Endpoints

Primary: Clinician-Administered PTSD Scale for DSM-5 (CAPS-5)

Secondary: PTSD Checklist for DSM-5 (PCL-5)

Body systems

Psychiatry / Mental Health